funder-graph

FundersNHAdvancing Cancer Treatment › 2022

Grants paid by Advancing Cancer Treatment, tax year 2022

EIN 83-2886283 · Moultonboro, NH · Form 990, Schedule I · NTEE G12

In tax year 2022, Advancing Cancer Treatment (EIN 83-2886283) reported 6 grants paid totaling $0. Dataset version 2026.09.0, built 2026-09-03.

2020202220232024

Every grant, 2022

Grants reported by Advancing Cancer Treatment for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Georgia Core Inc Atlanta, GAA$0paid110000202322339349300982
2022Prostate Health Ed Network Quincy, MAA$0paid45000202322339349300982
2022Gumo Finance Seattle, WAA$0paid75000202322339349300982
2022Pcec Englewood, COA$0paid2314266202322339349300982
2022Zero Alexandria, VAA$0paid89500202322339349300982
2022Johns Hopkins Manchester, MDA$0paid75000202322339349300982

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.